The use of HEPES-buffer in the production of gallium-68 radiopharmaceuticals – time to reconsider strict pharmacopoeial limits?
Abstract HEPES (4-(2-hydroxyethyl) piperazine-1-ethanesulfonic acid) is a buffer that is used in the radiolabelling of gallium-68 compounds. The beneficial effects of HEPES on molar activity in bioconjugates have been well described. Current strict regulations on the HEPES content in radiopharmaceut...
Main Authors: | Jannie le Roux, Janke Kleynhans, Sietske Rubow |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2021-04-01
|
Series: | EJNMMI Radiopharmacy and Chemistry |
Subjects: | |
Online Access: | https://doi.org/10.1186/s41181-021-00129-w |
Similar Items
-
New sensitive method for HEPES quantification in 68Ga-radiopharmaceuticals
by: I. F. Antunes, et al.
Published: (2020-05-01) -
Development and evaluation of a rapid analysis for HEPES determination in 68Ga-radiotracers
by: Sarah Pfaff, et al.
Published: (2018-10-01) -
Gallium‐68 DOTATATE Production with Automated PET Radiopharmaceutical Synthesis System: A Three Year Experience
by: Alireza Aslani, et al.
Published: (2014-10-01) -
Temperature impact on [68Ga]Ga-edotreotide for the shipping of radioactive material in shielded container
by: Schmitt Camille, et al.
Published: (2020-05-01) -
Two Novel PET Radiopharmaceuticals for Endothelial Vascular Cell Adhesion Molecule-1 (VCAM-1) Targeting
by: Sara Pastorino, et al.
Published: (2021-07-01)